We aimed to assess the burden of extended-spectrum β-lactamase (ESBL)-producing in Swiss long-term care facilities (LTCFs) to describe the molecular epidemiology, describe the intrainstitutional and regional clusters of resistant pathogens, and identify independent institution- and resident-level factors ...
A new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed by the Food and Drug Administration (FDA) in May 2023 for adults 60 years of age and older.